Inactive Instrument
Oncternal Therapeutics, Inc. Stock
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
| 1 day | -24.11% |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 01/04/2017 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2023 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Dan Kisner
BRD | Director/Board Member | 79 | 07/06/2019 |
William LaRue
BRD | Director/Board Member | 75 | 01/12/2017 |
Xin Nakanishi
BRD | Director/Board Member | 64 | 01/11/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/6/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/6/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/6/24 | Free | Director | 2,200 | 0.0743% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -24.11% | -25.83% | - | - | 1.56M | ||
| +1.15% | -2.81% | +55.79% | +71.12% | 66.37B | ||
| -2.64% | -1.13% | +7.82% | +88.90% | 58.86B | ||
| -1.07% | +0.30% | +22.91% | +86.76% | 55.22B | ||
| +0.48% | -2.53% | +9.73% | +121.14% | 47.21B | ||
| -2.69% | -6.38% | +19.19% | +25.79% | 42.45B | ||
| -0.70% | +4.93% | +17.77% | +45.03% | 36.44B | ||
| -2.50% | -15.73% | +135.31% | +662.73% | 35.19B | ||
| -0.77% | -2.21% | +77.27% | +57.96% | 32.66B | ||
| -0.83% | +1.98% | -38.27% | +390.98% | 26.73B | ||
| Average | -3.37% | -2.29% | +34.17% | +172.27% | 45B | |
| Weighted average by Cap. | -0.97% | -2.18% | +33.93% | +146.74% |
Employees
29
















